Nu-Med Plus (NUMD) Total Debt (QoQ) (2013 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -92.54% |
| Sep 30, 2020 | 3.34% |
| Jun 30, 2020 | 2.88% |
| Mar 31, 2020 | 3.52% |
| Dec 31, 2019 | 3,780.13% |
| Sep 30, 2019 | -48.78% |
| Jun 30, 2019 | -31.71% |
| Mar 31, 2019 | -61.60% |
| Dec 31, 2018 | 63.82% |
| Sep 30, 2018 | -14.70% |
| Jun 30, 2018 | -12.27% |
| Mar 31, 2018 | -10.46% |
| Dec 31, 2017 | -9.07% |
| Sep 30, 2017 | -7.94% |
| Jun 30, 2013 | 48.32% |
| Mar 31, 2013 | 101.56% |